The last few years have seen dramatic growth in outsourcing to India in all areas of technology.
The trend has been particularly noticeable in the pharmaceuticals sector. Leading pharmaceutical firms across the world are increasingly turning to India to outsource processes and solutions as part of their efforts to bring down the price of drugs.
Drug makers operating in US could save at least 60 per cent in producing new drugs by outsourcing R&D and other services to India; it is estimated. In this way, we come in to picture. DELPHIS PHARMA is pharma house which offers third-party manufacturing for domestic and export formulations with optimum quality at most competitive rates with excellent backup team to ensure on Schedule delivery.
Delphis Pharma is in Contract – Manufacturer of pharmaceuticals formulation and growing from strength since 5 years of commitment and sound knowledge of good Contract – manufacturing practices with WHO GMP Standards, Schedule ‘M’ Compliance with a knowledge to provide innovative healthcare products.